Lv51
910 积分 2024-01-12 加入
Cancer immunotherapy comes of age
7小时前
待确认
PD-1 signaling limits expression of phospholipid phosphatase 1 and promotes intratumoral CD8+ T cell ferroptosis
5天前
已完结
Interruption of the intratumor CD8+ T cell:Treg crosstalk improves the efficacy of PD-1 immunotherapy
5天前
已完结
1718O EREMISS trial: A double-blind placebo (PBO)-controlled randomised trial assessing efficacy/safety of regorafenib (REGO) as maintenance therapy after 1st line doxorubicin-based chemotherapy in advanced soft-tissue sarcoma (ASTS) patients (pts)
17天前
已完结
Advances in research based on antibody-cell conjugation
19天前
已完结
ALK-positive lung cancer: a moving target
19天前
已完结
Targeted therapy for advanced anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer
19天前
已完结
Small-molecule MDM2 inhibitors in clinical trials for cancer therapy
20天前
已完结
1719O Multisarc: A randomized precision medicine study in advanced soft-tissue sarcomas
1个月前
已完结
Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trial
1个月前
已完结
皖公网安备34019202002308
